Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISS - Albumin Replacement Therapy in Septic Shock
DRKS00017475Phase 3Terminated
- Sponsor
- Friedrich Schiller University Jena
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in septic shock comparing Human albumin replacement with Standard of care (crystalloids) (2 arms). Started Jul 2019; status: terminated.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on DRKS00017475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017475.